相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Dynamics of pseudo-atrophy in RRMS reveals predominant gray matter compartmentalization
Nicola De Stefano et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2021)
MAGNIMS consensus recommendations on the use of brain and spinal cord atrophy measures in clinical practice
Jaume Sastre-Garriga et al.
NATURE REVIEWS NEUROLOGY (2020)
Neurotoxicity after hematopoietic stem cell transplant in multiple sclerosis
Simon Thebault et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2020)
SIENA-XL for Improving the Assessment of Gray and White Matter Volume Changes on Brain MRI
Marco Battaglini et al.
HUMAN BRAIN MAPPING (2018)
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets
Nicola De Stefano et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis
Hyunwoo Lee et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Reduced brain atrophy rates are associated with lower risk of disability progression in patients with relapsing multiple sclerosis treated with cladribine tablets
Nicola De Stefano et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Impact of immunoablation and autologous hematopoietic stem cell transplantation on gray and white matter atrophy in multiple sclerosis
Hyunwoo Lee et al.
MULTIPLE SCLEROSIS JOURNAL (2018)
Cladribine treatment of multiple sclerosis is associated with depletion of memory B cells
Bryan Ceronie et al.
JOURNAL OF NEUROLOGY (2018)
Cladribine: mechanisms and mysteries in multiple sclerosis
Benjamin Meir Jacobs et al.
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2018)
Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting
Carmen Tur et al.
NATURE REVIEWS NEUROLOGY (2018)
Brain atrophy after bone marrow transplantation for treatment of multiple sclerosis
Hyunwoo Lee et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Brain atrophy after bone marrow transplantation for treatment of multiple sclerosis
Hyunwoo Lee et al.
MULTIPLE SCLEROSIS JOURNAL (2017)
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
S. L. Hauser et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
X. Montalban et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics
Angela Vidal-Jordana et al.
JOURNAL OF NEUROIMAGING (2016)
Exploring the origins of grey matter damage in multiple sclerosis
Massimiliano Calabrese et al.
NATURE REVIEWS NEUROSCIENCE (2015)
Treatment Effect on Brain Atrophy Correlates with Treatment Effect on Disability in Multiple Sclerosis
Maria Pia Sormani et al.
ANNALS OF NEUROLOGY (2014)
Effects of delayed-release dimethyl fumarate on MRI measures in the Phase 3 DEFINE study
Douglas L. Arnold et al.
JOURNAL OF NEUROLOGY (2014)
Correlation between brain volume change and T2 relaxation time induced by dehydration and rehydration: Implications for monitoring atrophy in clinical studies
Kunio Nakamura et al.
NEUROIMAGE-CLINICAL (2014)
Evaluating and reducing the impact of white matter lesions on brain volume measurements
Marco Battaglini et al.
HUMAN BRAIN MAPPING (2012)
Assessing brain atrophy rates in a large population of untreated multiple sclerosis subtypes
N. De Stefano et al.
NEUROLOGY (2010)
A Placebo-Controlled Trial of Oral Cladribine for Relapsing Multiple Sclerosis
Gavin Giovannoni et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Disability and T2 MRI lesions:: a 20-year follow-up of patients with relapse onset of multiple sclerosis
L. K. Fisniku et al.
BRAIN (2008)
Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm
YY Zhang et al.
IEEE TRANSACTIONS ON MEDICAL IMAGING (2001)
分享论文
